Community Health Systems, Inc. (NYSE:CYH) went lower by -0.18% to close at $ 11.14. The company exchanged total volume of 5.57 million shares throughout course of last trade however it holds an average trading capacity of 4.86 million shares. Shares of company began trading at $11.05 climbed to high of $11.54 touched the low of $11.00.
The company is trading above its 50-day moving averages of 10.69 and down from 200-day moving averages of 13.18. The firm has price to book ratio of 0.65 and its price to sale ratio was 0.06.
The stock has received ratings from many brokerage firms according to ZACKS. Currently shares have been rated as “Buy” from “13” brokerage firms and “0” brokerage firms say as “Strong Buy”. “1” brokerage firms have suggested “Sell” for the company. “1” brokerage firms have recommended as a “Hold”. Strong Sell rating was given by “2.94” brokerage firms. The Company has average brokerage recommendation (ABR) of “2.13” based on consensus of the ZACKS brokerage firms.
The average true range of Community Health Systems, Inc.’s (CYH) is recorded at 0.68 and the relative strength index of the stock stands 52.18. The stock price is going above to its 52 week low with 15.32% and lagging behind from its 52 week high with -70.34%. Analyst recommendation for this stock stands at 3.00. A look on the firm performance, its monthly performance is 3.92% and a quarterly performance of -7.55%. The stock price is trading downbeat from its 200 days moving average with -22.37% and down from 50 days moving average with -1.21%.
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) dropped -3.1757% and closed the trade at $ 0.5549. The company recorded a trading capacity of 1.09 million shares below its three months average daily volume of 2.11 million shares. During the last trade, shares reached to high price of $0.6000 and touched the low price of $0.5500. The stock’s 50-day moving average is noted at $0.4380 and its 200-day moving average is stands at $0.8282.
Additionally, the company has EPS of -0.2660. The company has market capitalization of $63.12M.
Northwest Biotherapeutics, Inc.’s (NWBO) has price-to-cash ratio of 30.04 and price to sale ratio of 42.06. A look on the firm performance, its monthly performance is 65.39% and a quarterly performance of -4.54%. The stock price is moving up from its 20 days moving average with 15.95% and isolated positively from 50 days moving average with 25.73%.